| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/12/2008 | EP1897441A1 TGF-alpha polypeptides, functional fragments and methods of use therefor |
| 03/12/2008 | EP1896855A2 Biomarkers for breast cancer |
| 03/12/2008 | EP1896601A1 Bioactive agents produced by submerged cultivation of a basidiomycete cell |
| 03/12/2008 | EP1896507A2 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
| 03/12/2008 | EP1896491A2 Monoazole ligand platinum analogs |
| 03/12/2008 | EP1896489A1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof |
| 03/12/2008 | EP1896480A1 Cripowellins and synthetic derivatives thereof used as medicaments |
| 03/12/2008 | EP1896475A2 Process for the preparation of bicyclic compounds |
| 03/12/2008 | EP1896472A1 Alpha-carbolines as cdk-1 inhibitors |
| 03/12/2008 | EP1896470A2 Pyrrolopyridine derivatives as protein kinase inhibitors |
| 03/12/2008 | EP1896461A2 Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer |
| 03/12/2008 | EP1896451A2 Bicyclic derivatives for the treatment of abnormal cell growth |
| 03/12/2008 | EP1896429A2 A purification process for anastrozole intermediate |
| 03/12/2008 | EP1896422A2 Tyrosine kinase inhibitors |
| 03/12/2008 | EP1896418A1 Quinoline 3 -sulfonate esters as nk3 receptor modulators |
| 03/12/2008 | EP1896416A1 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them |
| 03/12/2008 | EP1896412A2 Oxindole derivatives |
| 03/12/2008 | EP1896399A1 Biphenyl and naphthyl-phenyl hydroxamic acid derivatives |
| 03/12/2008 | EP1896398A2 An impurity of anastrozole intermediate, and uses thereof |
| 03/12/2008 | EP1896391A2 Combretastatin analogs with tubulin binding activity |
| 03/12/2008 | EP1896075A2 Pharmaceutical compositions comprising tacrolimus and a cyp3a4 inhibitor |
| 03/12/2008 | EP1896053A1 Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use |
| 03/12/2008 | EP1896051A2 Method of treating patients with a mucinous glycoprotein (muc-1) vaccine |
| 03/12/2008 | EP1896040A2 Phosphoramidate alkylator prodrugs |
| 03/12/2008 | EP1896035A2 Carbazole formulations for the treatment of psoriasis and angiogenesis |
| 03/12/2008 | EP1896030A1 Combinations of erbb2 inhibitors with other therapeutic agents in the treatment of cancer |
| 03/12/2008 | EP1896029A1 Aminopyrimidines as kinase modulators |
| 03/12/2008 | EP1896020A1 Inhibition of osteolytic lesions by src kinase inhibitors |
| 03/12/2008 | EP1896018A2 Medical uses of 39-desmethoxyrapamycin and analogues thereof |
| 03/12/2008 | EP1895999A1 Use of non-steroidal progesterone receptor modulators |
| 03/12/2008 | EP1745780A4 Medicinal preparation |
| 03/12/2008 | EP1705182A4 Antitumoral and antiviral peptides |
| 03/12/2008 | EP1594896B1 Modified soluble t cell receptor |
| 03/12/2008 | EP1539693B1 Cannabinoid receptor agonists |
| 03/12/2008 | EP1537872A4 Immunostimulator having antineoplastic action and method for producing said immunostimulator |
| 03/12/2008 | EP1506317B1 Marker molecules associated with lung tumors |
| 03/12/2008 | EP1427395B1 Stabilization of active agents by formulation into nanoparticulate form |
| 03/12/2008 | EP1416935B1 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives |
| 03/12/2008 | EP1414809B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 03/12/2008 | EP1411986B1 Composition comprising epigallocatechin gallate |
| 03/12/2008 | EP1408999B1 Compositions addressing inflammation and/or degenerative disorders |
| 03/12/2008 | EP1210434B1 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 03/12/2008 | EP0614374B2 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 03/12/2008 | CN101142232A KUNITZ-type recombinant inhibitor |
| 03/12/2008 | CN101142229A Htm4 used for cell-cycle regulation through its interaction with kap |
| 03/12/2008 | CN101142202A Anticancer compound, intermediate therefor, and processes for producing these |
| 03/12/2008 | CN101142198A Isoxazole combretastatin derivatives for the treatment of proliferative disorders |
| 03/12/2008 | CN101141960A Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione |
| 03/12/2008 | CN101141955A Antitumor combination comprising substituted acryloyl distamycin derivatives and antibodies inhibiting growth factors or their receptors |
| 03/12/2008 | CN101139613A Antineoplastic dibasic polypeptide and application and preparation method thereof |
| 03/12/2008 | CN101139591A Small molecule RNA of shark liver and use thereof |
| 03/12/2008 | CN101139399A Fused protein restructuring target lethal leukemia cells and preparation method and use thereof |
| 03/12/2008 | CN101139394A Cytoplasma membrane surface antigen monoclonal antibody and uses thereof |
| 03/12/2008 | CN101139393A KDR peptides and vaccines containing the same |
| 03/12/2008 | CN101139392A KDR peptides and vaccines containing the same |
| 03/12/2008 | CN101139387A Recombinant soluble human FGFR2 extracellular fragment and production method and application thereof |
| 03/12/2008 | CN101139368A Histone deacetylase inhibitor organic tin polyacid compound and preparation method thereof |
| 03/12/2008 | CN101139358A Ethoxy combretastatin and preparation and use of its prodrug |
| 03/12/2008 | CN101139350A Oridonin derivative, preparation method and uses thereof |
| 03/12/2008 | CN101139347A Banisterine derivative compound and uses thereof |
| 03/12/2008 | CN101139335A Use of 7-hydroxy-3-[(4-hydroxy)-3-((E)-3,7-dimethyl-octyl-2,6-diolefin)phenyl]-4H-1-benzopyran-4-ketone |
| 03/12/2008 | CN101139292A 4'-oxo carboxyl acid diphenyl ethylene alkyl derivative |
| 03/12/2008 | CN101138637A Antineoplastic medicament and adenovirus composite preparations and uses thereof |
| 03/12/2008 | CN101138634A Composition for treating tumour |
| 03/12/2008 | CN101138629A Recombinant human keratinocyte growth factor-2 freeze dried agent |
| 03/12/2008 | CN101138612A Antineoplastic preparations and method of preparing the same |
| 03/12/2008 | CN101138569A Pharmaceutical composition for improving curative effect of indole-3-methanol and derivant thereof |
| 03/12/2008 | CN101138564A Application of alkaloids compounds in the preparation of antineoplastic medicament |
| 03/12/2008 | CN101138558A Pentamidine and death domain receptor ligand united application |
| 03/12/2008 | CN101138548A Polyglycol derivatization phospholipid loaded vinorelbine nano-micelle preparations |
| 03/12/2008 | CN101138546A Restrainer containing tyrosine kinase and anticancer hormone medicines composition |
| 03/12/2008 | CN100374575C Method of estimating the risk of expression of adverse drug reaction caused by the administration of a compound, which is either metabolized per se by UGT1A1 enzyme or whose metabolic intermediate is |
| 03/12/2008 | CN100374573C Carrier PCD-VEGF able to stable express VEGF shRNA |
| 03/12/2008 | CN100374568C TAO protein kinases and methods of use thereof |
| 03/12/2008 | CN100374550C Magnetic cell and method of using the same |
| 03/12/2008 | CN100374548C BCG vaccine strain of recombined interferon and its preparation process |
| 03/12/2008 | CN100374463C Method for preparing nanometer realgar gel and nanometer realgar with biomacromolecule template to regulate shape and particle thereof |
| 03/12/2008 | CN100374456C Specific human antibodies for selective cancer therapy |
| 03/12/2008 | CN100374444C Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 03/12/2008 | CN100374443C Hydrophilic polymer-thunder good vine extract binding substance and its medicinal composition |
| 03/12/2008 | CN100374435C Substd. pyridines and pyridazines with angiogenesis inhibiting activity |
| 03/12/2008 | CN100374425C Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers |
| 03/12/2008 | CN100374164C Recombinant plasmid for curing prostate gland cancer and melanoma |
| 03/12/2008 | CN100374163C Composition for the enhancement of the efficacy of drugs |
| 03/12/2008 | CN100374162C application of seasquirts-743 on preparing agent for the treatment of tumor |
| 03/12/2008 | CN100374160C Anti-cancer medicine composition containing antimetabolite |
| 03/12/2008 | CN100374158C application of agent for lowering the cell ATP level in preparing medicine |
| 03/12/2008 | CN100374116C Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy |
| 03/12/2008 | CN100374106C High nurity elemene anti-cancer medicine and its preparing method |
| 03/12/2008 | CN100374105C Glabrous sarcandra herb lyophilized powder for injection, its high-dose injection and preparing method |
| 03/11/2008 | US7342125 Administering derivatives of Kauranoic acid; cachexia, analgesics, in treating immune disorders, as anti-cancer and anti-tumor agents, otitis media, sinusitis, antidiabetic agent |
| 03/11/2008 | US7342105 Antibody and use thereof |
| 03/11/2008 | US7342095 Peptidomimetic inhibitors of STAT activity and uses thereof |
| 03/11/2008 | US7342094 Tumor vaccines for MUC1-positive carcinomas |
| 03/11/2008 | US7342092 Vaccines as dosage forms; acute myeloblastic leukemia |
| 03/11/2008 | US7342045 Stabilized ascorbic acid solutions; use thereof; process for their obtention; and formulations comprising the same |
| 03/11/2008 | US7342034 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/11/2008 | US7342032 Psychiatric and neurological disorders; cannabinoid (cb1) receptor; such as 4-(4-Chlorophenyl)-5-(2,4-dichlorophenyl)-N-(1-piperidinyl)thiazole-2-carboxamide |
| 03/11/2008 | US7342029 Substituted indoles |
| 03/11/2008 | US7342025 Substituted C-imidazo[1,2-a]pyridin-3-yl-methylamines |